Biorem Inc (TSE:BRM)
:BRM
Want to see TSE:BRM full AI Analyst Report?
Top Page
Biorem Inc
(BRM)
Select Model
Select Model
Rating:82Outperform
Price Target:
C$3.50
▲(32.08% Upside)
Action:UpgradedDate:04/24/26
The score is driven primarily by improving financial performance (strong growth, margin expansion, better leverage, and stronger 2025 cash generation) plus supportive valuation (low P/E). Technicals are positive but slightly tempered by overbought signals (RSI/Stoch), which adds near-term risk.
Positive Factors
Revenue & Margin Expansion
Biorem’s 2025 revenue growth (~22%) and margin expansion (net ~11% vs ~8%) reflect improved operating leverage and scalable project economics. Sustained higher margins bolster internal cash for aftermarket services and reinvestment, supporting durable profitability and ability to fund growth over coming quarters.
Negative Factors
Historical Revenue & Earnings Volatility
Biorem’s multi-year trend includes notable volatility, including a 2023 revenue decline, indicating sensitivity to project cycles and end-market demand. This uneven growth undermines predictability for bookings, margins and cash flow, making operational planning and steady margin expansion harder to sustain over time.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Margin Expansion
Biorem’s 2025 revenue growth (~22%) and margin expansion (net ~11% vs ~8%) reflect improved operating leverage and scalable project economics. Sustained higher margins bolster internal cash for aftermarket services and reinvestment, supporting durable profitability and ability to fund growth over coming quarters.
Read all positive factors
Biorem Inc (BRM) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$52.22M
Dividend YieldN/A
Average Volume (3M)32.44K
Price to Earnings (P/E)9.0
Beta (1Y)0.53
Revenue Growth13.19%
EPS Growth55.21%
CountryCA
Employees57
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,117,027
10 Day Avg. Volume30,537
30 Day Avg. Volume32,440
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.90
Price to Sales (P/S)1.02
P/FCF Ratio5.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$45.20M
Biorem Inc Business Overview & Revenue Model
Company Description
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers bi...
How the Company Makes Money
Biorem makes money primarily by selling engineered air emissions control projects and related services. Its key revenue stream is the design and supply of air pollution control systems (typically delivered as engineered-to-order equipment packages...
Biorem Inc Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
82
Very Positive
Cash Flow
78
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 42.36M | 37.42M | 25.17M | 28.86M | 24.48M |
| Gross Profit | 12.59M | 10.06M | 7.02M | 8.76M | 6.24M |
| EBITDA | 7.05M | 4.82M | 3.45M | 2.99M | 2.68M |
| Net Income | 4.82M | 3.04M | 2.18M | 1.61M | 1.30M |
Balance Sheet | |||||
| Total Assets | 33.58M | 28.51M | 24.08M | 20.73M | 19.17M |
| Cash, Cash Equivalents and Short-Term Investments | 11.50M | 5.21M | 2.29M | 3.78M | 4.47M |
| Total Debt | 2.83M | 3.56M | 4.19M | 4.75M | 5.67M |
| Total Liabilities | 18.65M | 17.89M | 17.36M | 16.21M | 17.20M |
| Stockholders Equity | 14.93M | 10.63M | 6.72M | 4.52M | 1.96M |
Cash Flow | |||||
| Free Cash Flow | 7.27M | 3.31M | -62.84K | 1.24M | 3.71M |
| Operating Cash Flow | 7.64M | 3.69M | 490.03K | 1.44M | 3.78M |
| Investing Cash Flow | -367.83K | -372.00K | -552.87K | -203.29K | -75.98K |
| Financing Cash Flow | -767.05K | -572.04K | -1.33M | -951.80K | -7.56M |
Biorem Inc Technical Analysis
Positive
2.65
Price Trends
2.56
Positive
2.55
Positive
2.33
Positive
Market Momentum
>-0.01
Negative
58.35
Neutral
94.44
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BRM, the sentiment is Positive. The current price of 2.65 is above the 20-day moving average (MA) of 2.48, above the 50-day MA of 2.56, and above the 200-day MA of 2.33, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 58.35 is Neutral, neither overbought nor oversold. The STOCH value of 94.44 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:BRM.
Biorem Inc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | C$52.22M | 8.99 | 39.51% | ― | 13.19% | 55.21% | |
62 Neutral | C$28.17M | 9.22 | 13.24% | ― | -3.43% | -14.29% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | C$1.60M | -14.31 | 24.47% | ― | -27.49% | -32.97% | |
49 Neutral | C$8.89M | -6.80 | -7.46% | ― | 50.33% | 49.57% | |
49 Neutral | C$35.90M | -34.71 | -4.33% | ― | -14.26% | 28.26% | |
42 Neutral | C$14.77M | -4.72 | 399.66% | ― | 14.18% | -29.19% |
* General Sector Average
TSE:BRM
Biorem Inc
3.20
1.35
72.97%
TSE:DST
Dundee Sustainable Technologies
0.03
-0.16
-86.11%
TSE:SHRC
Sharc International Systems Inc
0.09
0.00
0.00%
TSE:QST
Questor Technology
0.32
0.05
18.52%
TSE:TMG
Thermal Energy International
0.16
0.04
34.78%
TSE:GRN
Greenlane Renewables Inc
0.22
0.13
144.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.